Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Hui Wen Fan a Hospital Vital
Brazil, Instituto Butantan, Avenue Vital Brazil 1500, 05503-900, São
Paulo, Brazil, b Division
of Epidemiology, Escola Paulista de Medicina, Unifesp, 04039-032, São
Paulo, Brazil, c Alistair Reid Venom Research Unit, Liverpool School of
Tropical Medicine, Pembroke Place, Liverpool L3 5QA, d Centre for Tropical
Medicine, University of Oxford, John Radcliffe Hospital, Headington,
Oxford OX3 9DU
Correspondence to: Dr H W Fan
fhui{at}uol.com.br
Objective:
To investigate the efficacy of the
H1 antihistamine promethazine against early
anaphylactic reactions to antivenom.
Design:
Sequential randomised, double blind, placebo controlled trial.
Setting:
Public hospital in a venom research
institute, São Paulo, Brazil.
Participants:
101 patients requiring antivenom
treatment after being bitten by bothrops snakes.
Intervention:
Intramuscular injection of promethazine
(25 mg for adults and 0.5/kg for children) or placebo given 15-20 min
before starting intravenous infusion of antivenom.
Main outcome measures:
Incidence and severity of
anaphylactic reactions occurring within 24 hours after antivenom.
Results:
Reactions occurred in 12 of 49 patients
treated with promethazine (24%) and in 13 of 52 given placebo (25%);
most were mild or moderate. Continuous sequential analysis indicated that the study could be interrupted at the 22nd
untied pair, without preference for promethazine or placebo.
Conclusion:
Prophylaxis with promethazine does not
prevent early reactions. Patients should be observed carefully during antivenom infusion and the subsequent few hours.
Key messages
Read all Rapid Responses